Aug 07 (Reuters) - Nuvation Bio Q2 income from pperations USD -63.589 million.
Q2 revenue USD 1.238 million vs. IBES estimate USD 357.1 thousand
Q2 operating expenses USD 65.846 million
Q2 pretax profit USD -59.007 million
Q2 net income USD -59.007 million
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.